Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Benzoate for Hyperammonemia in Pediatric Chronic Liver Disease
NCT04022941Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Apr 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of sodium benzoate in hyperammonemia, sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Blood ammonia levels at 5 days. Started Apr 2017; status: completed.
02
Drugs
sodium benzoate
03
Conditions
hyperammonemia
Beyond the preview
Go deeper on NCT04022941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04022941.